Skip to main content

Table 3 Effect of exercise on quality of life, anxiety, and depression based on an intention-to-treat analysis

From: Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial

Ā Ā Ā 

Baseline to 18Ā weeks (i.e., post intervention)

Baseline to 36Ā weeks

Ā Ā 

Baseline

Within-group difference

Between-group difference

Within-group difference

Between-group difference

Ā Ā 

Mean (SD)

Mean

[95Ā % CI]

Mean

[95Ā % CI]

ES

Mean

[95Ā % CI]

Mean

[95Ā % CI]

ES

EORTC questionnaire

Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒQuality of life

UC

72.5 (19.4)

āˆ’4.5

[āˆ’8.8 to āˆ’0.3]

Ā 

Reference

Ā 

5.5

[1.2 to 9.9]

Ā 

Reference

Ā 
Ā 

I

74.8 (20.4)

āˆ’4.4

[āˆ’8.4 to āˆ’0.4]

2.3

[āˆ’2.4 to 6.9]

0.11

4.2

[0.0 to 8.3]

0.7

[āˆ’4.1 to 5.5]

0.03

ā€ƒPhysical functioning

UC

85.0 (14.3)

āˆ’5.8

[āˆ’9.1 to āˆ’2.5]

Ā 

Reference

Ā 

0.8

[āˆ’2.5 to 4.2]

Ā 

Reference

Ā 
Ā 

I

85.3 (14.2)

āˆ’4.2

[āˆ’7.3 to āˆ’1.1]

2.2

[āˆ’2.1 to 6.6]

0.16

0.4

[āˆ’2.8 to 3.6]

0.0

[āˆ’4.5 to 4.5]

0.00

ā€ƒRole functioning

UC

69.1 (23.6)

āˆ’6.7

[āˆ’12.4 to āˆ’1.0]

Ā 

Reference

Ā 

6.1

[0.3 to 11.9]

Ā 

Reference

Ā 
Ā 

I

69.8 (23.5)

āˆ’1.3

[āˆ’6.7 to 4.1]

5.9

[āˆ’1.1 to 12.9]

0.25

10.4

[4.8 to 15.9]

4.1

[āˆ’3.1 to 11.4]

0.18

ā€ƒEmotional functioning

UC

79.2 (17.9)

2.5

[āˆ’1.0 to 6.0]

Ā 

Reference

Ā 

4.3

[0.7 to 7.9]

Ā 

Reference

Ā 
Ā 

I

80.9 (18.2)

0.9

[āˆ’2.3 to 4.2]

āˆ’0.6

[āˆ’5.3 to 4.1]

āˆ’0.03

0.4

[āˆ’3.0 to 3.7]

āˆ’3.0

[āˆ’7.8 to 1.9]

āˆ’0.16

ā€ƒCognitive functioning

UC

81.7 (23.4)

āˆ’7.8

[āˆ’13.1 to āˆ’2.5]

Ā 

Reference

Ā 

āˆ’6.9

[āˆ’12.3 to āˆ’1.5]

Ā 

Reference

Ā 
Ā 

I

78.8 (23.6)

āˆ’10.1

[āˆ’15.1 to āˆ’5.1]

āˆ’4.4

[āˆ’11.3 to 2.5]

āˆ’0.19

āˆ’7.0

[āˆ’12.1 to āˆ’1.8]

āˆ’2.0

[āˆ’9.2 to 5.1]

āˆ’0.09

ā€ƒSocial functioning

UC

80.9 (22.2)

āˆ’9.0

[āˆ’14.2 to āˆ’3.7]

Ā 

Reference

Ā 

1.3

[āˆ’4.1 to 6.7]

Ā 

Reference

Ā 
Ā 

I

80.6 (22.0)

āˆ’7.6

[āˆ’12.6 to āˆ’2.7]

1.0

[āˆ’5.3 to 7.3]

0.04

3.7

[āˆ’1.4 to 8.9]

1.3

[āˆ’5.1 to 7.8]

0.06

ā€ƒFatigue

UC

33.4 (23.4)

9.0

[3.9 to 14.1]

Ā 

Reference

Ā 

āˆ’1.5

[āˆ’6.7 to 3.7]

Ā 

Reference

Ā 
Ā 

I

32.2 (25.1)

7.4

[2.5 to 12.2]

āˆ’3.0

[āˆ’9.1 to 3.1]

āˆ’0.12

āˆ’3.9

[āˆ’8.8 to 1.1]

āˆ’2.6

[āˆ’8.9 to 3.7]

āˆ’0.11

ā€ƒPain

UC

22.9 (25.4)

āˆ’0.4

[āˆ’5.7 to 4.8]

Ā 

Reference

Ā 

āˆ’0.6

[āˆ’6.0 to 4.8]

Ā 

Reference

Ā 
Ā 

I

24.0 (23.2)

āˆ’3.1

[āˆ’8.1 to 1.8]

āˆ’3.0

[āˆ’9.4 to 3.5]

āˆ’0.12

āˆ’0.5

[āˆ’5.7 to 4.6]

āˆ’0.1

[āˆ’6.7 to 6.6]

0.00

Hospital Anxiety and Depression Scale questionnaire

Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒDepression

UC

2.4 (2.7)

1.0

[0.4 to 1.5]

Ā 

Reference

Ā 

0.0

[āˆ’0.6 to 0.6]

Ā 

Reference

Ā 
Ā 

I

2.5 (3.1)

0.8

[0.3 to 1.3]

0.0

[āˆ’0.8 to 0.7]

āˆ’0.01

0.0

[āˆ’0.5 to 0.6]

0.2

[āˆ’0.6 to 0.9]

0.06

ā€ƒAnxiety

UC

4.2 (3.0)

āˆ’0.5

[āˆ’1.1 to 0.1]

Ā 

Reference

Ā 

āˆ’0.3

[āˆ’0.9 to 0.3]

Ā 

Reference

Ā 
Ā 

I

4.4 (3.4)

āˆ’0.2

[āˆ’0.8 to 0.3]

0.2

[āˆ’0.6 to 1.0]

0.06

0.2

[āˆ’0.4 to 0.8]

0.5

[āˆ’0.4 to 1.3]

0.15

  1. ES effect size, I intervention group, UC usual care group
  2. Negative ES for fatigue, pain, anxiety, and depression and positive ES for quality of life, physical functioning, role functioning, emotional functioning, cognitive functioning and social functioning indicate effects in favour of the exercise intervention group
  3. Between-group effects were assessed using mixed models including the measurements obtained at 18 and 36Ā weeks, adjusted for age, hospital, radiotherapy, use of tissue expander, receptor status and the value of the outcome variable at baseline
  4. Within-group effects were assessed using mixed models including the measurements obtained at baseline, 18 and 36Ā weeks, adjusted for age, hospital, radiotherapy, use of tissue expander, and receptor status
  5. Baseline results and within-group differences were based on participants having baseline measurements (102 participants in each group). Between-group differences were based on participants for whom measurements at 18 or 36Ā weeks were available (93 intervention and 89 usual care)